Evaluation of Different Teaching- and Learningmethods

Evaluation of Different Teaching- and Learningmethods Concerning the Humeral Intraosseal Access in Inexperienced Providers

Due to the corona pandemia and the consecutive reduction of teaching students face to face the imparting of medical skills is limited. Video sequences may be an adequate alternative to educate selected practical skills. The investigators explored this aspect in spring 2021 concerning the humeral intraosseous access. This study was registered under ClinicalTrials: NCT04842357. Data is still under statistical analysis and not published yet. As a secondary endpoint we found participant having done self-study first and watched a teaching-video one week later performed better than participant in the vice versa sequence. This may have important curricular implications. So, we launch the present study to investigate, if the sequence: Self-Study, then Teaching-Video is more efficient than vice versa.

Study Overview

• Status: Completed
• Conditions: Education, Medical; Complication of Infusion
• Intervention / Treatment: Other: Sequence of teaching-/learningmethod

Detailed Description

The investigators will recruit last year medical students and randomise them into two groups: Group A and Group B. Group A will watch a standardised video about the skill, then directly do self-study. Group B will do self-study and then directly watch a standardised video. Right after this, both groups will be video recorded during the performance of the skill: humeral intraosseous access on a simulator. The performance will be quantified by a scale by two investigators

• Study Type: Interventional
• Enrollment (Actual): 40
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Germany
  • RLP
    • Mainz, RLP, Germany, 55131
      • University Hospital Centre Mainz

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• voluteer medical students in their last year of medical school (i.e. after 2nd state board in Germany)
• writen informed consert

Exclusion Criteria:

• denial of participation

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Sequence: self-study, then teaching video; Participants first do self-study, then right afterwards watch a teaching video, then become tested on a simulator and are videorecorded for evaluation	Other: Sequence of teaching-/learningmethod; see: arm/group descriptions
Other: Sequence: teaching video, then self study; Participants first watch a teaching video, then do self-study, then become tested on a simulator and are videorecorded for evaluation	Other: Sequence of teaching-/learningmethod; see: arm/group descriptions

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
sum of score	sum of the score used to evaluate the particpants' performance by video records	1 Day

Collaborators and Investigators

• Sponsor: Johannes Gutenberg University Mainz

Study record dates

Study Major Dates

• Study Start (Actual): May 17, 2021
• Primary Completion (Actual): December 10, 2021
• Study Completion (Actual): March 29, 2022

Study Registration Dates

• First Submitted: September 23, 2021
• First Submitted That Met QC Criteria: September 23, 2021
• First Posted (Actual): October 4, 2021

Study Record Updates

• Last Update Posted (Actual): April 7, 2022
• Last Update Submitted That Met QC Criteria: March 29, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 2021-16112 EK RLP

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No